CD274 and neoplasm: The (7) PD-L1 cohort has gradually evolved into the (3) tumor-associated macrophages and (0) tumor-derived exosomes cohorts, reflecting the research process of tumor immune escape, which further promotes the exploration of the tumor microenvironment due to the differentiated efficacy of PD-L1-targeted drugs.